|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Investments, at fair value | |||||||||||||||
| From non-controlled/non-affiliated investments: | |||||||||||||||
| From non-controlled/affiliated investments: | |||||||||||||||
| Controlled/affiliated investments | |||||||||||||||
| Total investments, at fair value | |||||||||||||||
| Cash and cash equivalents (restricted cash of $29,172 and $3,820) | |||||||||||||||
| Investments in unaffiliated money market fund (cost of $11,216 and $12,976) | |||||||||||||||
| Deferred financing costs | |||||||||||||||
| Subscription receivable | |||||||||||||||
| Interest and dividend receivable from non-controlled/affiliated investments | |||||||||||||||
| Interest and dividend receivable from non-controlled/non-affiliated investments | |||||||||||||||
| Interest receivable from non-controlled/affiliated investments | |||||||||||||||
| Dividend receivable from controlled/affiliated investments | |||||||||||||||
| Receivable for investments sold/repaid | |||||||||||||||
| Prepaid expenses and other assets | |||||||||||||||
| Other assets | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities | |||||||||||||||
| Debt (net of unamortized debt issuance costs of $12,624 and $10,545) | |||||||||||||||
| Distributions payable | |||||||||||||||
| Management fees payable | |||||||||||||||
| Payable for Stock repurchased (Note 8) | |||||||||||||||
| Income based incentive fees payable | |||||||||||||||
| Interest payable | |||||||||||||||
| Payable for investment purchased | |||||||||||||||
| Payable to affiliates (Note 3) | |||||||||||||||
| Total payable to affiliates (Note 3) | |||||||||||||||
| Accrued expenses and other liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Net assets | |||||||||||||||
| Preferred stock, $0.001 par value (1,000,000 shares authorized; no shares issued and outstanding) | |||||||||||||||
| Common stock, par value $0.001 (500,000,000 shares authorized; 83,685,377 and 86,276,305 shares issued and outstanding) | |||||||||||||||
| Paid-in capital in excess of par value | |||||||||||||||
| Distributable earnings (loss) | |||||||||||||||
| Total net assets | |||||||||||||||
| Total liabilities and net assets | |||||||||||||||
| Net asset value per share | |||||||||||||||
Loading...